2004
DOI: 10.1097/00042728-200407000-00020
|View full text |Cite
|
Sign up to set email alerts
|

δ-Aminolevulinic Acid and Blue Light Photodynamic Therapy for Treatment of Multiple Basal Cell Carcinomas in Two Patients with Nevoid Basal Cell Carcinoma Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 14 publications
1
4
0
Order By: Relevance
“…This resulted in a reduction of the size and number of the existing BCCs, scars from previous excisions improved and the rate of tumour developing decreased 22 . Similar results are seen by Itkin et al 23 . They treated two patients with multiple superficial and nodular BCCs on the face and extremities.…”
Section: Introductionsupporting
confidence: 85%
“…This resulted in a reduction of the size and number of the existing BCCs, scars from previous excisions improved and the rate of tumour developing decreased 22 . Similar results are seen by Itkin et al 23 . They treated two patients with multiple superficial and nodular BCCs on the face and extremities.…”
Section: Introductionsupporting
confidence: 85%
“…While the frozen sections of the MMS procedure are being prepared and examined, illumination of the lesions can take place (Figure 4). Several case reports describe the use of PDT in patients with NBCCS 6,9,10 . Oseroff and colleagues, for example, noted a 90% to 98% clearance of BCCs in two children with NBCCS 6 .…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, PDT with δ‐aminolevulinic acid and a 417 nm blue light source is approved by the US Food and Drug Administration for the treatment of nonhypertrophic actinic keratoses. Furthermore, there is evidence that this therapeutic regimen is also effective in the treatment of superficial and nodular BCCs 12 …”
Section: Discussionmentioning
confidence: 99%